| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing inequities in access to care among Indigenous peoples with chronic hepatitis C in Alberta, Canada
|
Dunn, Kate P R
|
|
|
|
7 |
p. 590-592
|
artikel
|
| 2 |
A global scientific strategy to cure hepatitis B
|
Revill, Peter A
|
|
2019
|
|
7 |
p. 545-558
|
artikel
|
| 3 |
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
|
Matsuoka, Katsuyoshi
|
|
|
|
7 |
p. 648-657
|
artikel
|
| 4 |
Alcohol-related harm during the COVID-19 pandemic
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
7 |
p. 511
|
artikel
|
| 5 |
Aldafermin in non-alcoholic steatohepatitis: a cautionary tale for trial design
|
Tsochatzis, Emmanuel A
|
|
|
|
7 |
p. 586-587
|
artikel
|
| 6 |
Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial
|
Harrison, Stephen A
|
|
|
|
7 |
p. 603-616
|
artikel
|
| 7 |
Anal cancer screening in low-income and middle-income countries
|
Blair, Kevin J
|
|
|
|
7 |
p. 526
|
artikel
|
| 8 |
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
|
Qin, Shukui
|
|
|
|
7 |
p. 559-568
|
artikel
|
| 9 |
Are all post-ESWL pancreatitis events clinically significant?
|
Singh, Aniruddha Pratap Haripal
|
|
|
|
7 |
p. 593
|
artikel
|
| 10 |
Are all post-ESWL pancreatitis events clinically significant? – Authors' reply
|
Qian, Yang-Yang
|
|
|
|
7 |
p. 593-594
|
artikel
|
| 11 |
A simple non-invasive test for ruling out cirrhosis in chronic hepatitis B
|
Tseng, Tai-Chung
|
|
2019
|
|
7 |
p. 495-496
|
artikel
|
| 12 |
Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn's disease flare: a prospective cohort study
|
Ben-Horin, Shomron
|
|
2019
|
|
7 |
p. 519-528
|
artikel
|
| 13 |
A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis
|
Dossa, Fahima
|
|
2017
|
|
7 |
p. 501-513
|
artikel
|
| 14 |
Bacterial therapy for irritable bowel syndrome
|
Talley, Nicholas J
|
|
|
|
7 |
p. 627-629
|
artikel
|
| 15 |
Breaking the therapeutic ceiling in drug development in ulcerative colitis
|
Alsoud, Dahham
|
|
|
|
7 |
p. 589-595
|
artikel
|
| 16 |
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis
|
Powell, Nick
|
|
|
|
7 |
p. 679-697
|
artikel
|
| 17 |
Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial
|
Kurokawa, Yukinori
|
|
2018
|
|
7 |
p. 460-468
|
artikel
|
| 18 |
Can immunosuppression be stopped after liver transplantation?
|
Clavien, Pierre-Alain
|
|
2017
|
|
7 |
p. 531-537
|
artikel
|
| 19 |
Changes in colorectal cancer incidence in seven high-income countries: a population-based study
|
Araghi, Marzieh
|
|
2019
|
|
7 |
p. 511-518
|
artikel
|
| 20 |
Converging pandemics: implications of COVID-19 for the viral hepatitis response in sub-Saharan Africa
|
Gupta, Neil
|
|
|
|
7 |
p. 634-636
|
artikel
|
| 21 |
Correction to Lancet Gastoenterol Hepatol 2019; 4: 545–58
|
|
|
2019
|
|
7 |
p. e7
|
artikel
|
| 22 |
Correction to Lancet Gastroenterol Hepatol 2022; 7: 511–12
|
|
|
|
|
7 |
p. 600
|
artikel
|
| 23 |
Correction to Lancet Gastroenterol Hepatol 2022; 7: 617–26
|
|
|
|
|
7 |
p. 600
|
artikel
|
| 24 |
Correction to Lancet Gastroenterol Hepatol 2017; 2: 23–31
|
|
|
2017
|
|
7 |
p. e4
|
artikel
|
| 25 |
Correction to Lancet Gastroenterol Hepatol 2019; 4: 454–65
|
|
|
2019
|
|
7 |
p. e6
|
artikel
|
| 26 |
Correction to Lancet Gastroenterol Hepatol 2020; 5: 425–27
|
|
|
|
|
7 |
p. e6
|
artikel
|
| 27 |
Correction to Lancet Gastroenterol Hepatol 2020; 5: 649–57
|
|
|
|
|
7 |
p. e6
|
artikel
|
| 28 |
Correction to Lancet Gastroenterol Hepatol 2020; 5: 667–68
|
|
|
|
|
7 |
p. e6
|
artikel
|
| 29 |
Could a kiwifruit a day keep the doctor away?
|
Dimidi, Eirini
|
|
|
|
7 |
p. 648
|
artikel
|
| 30 |
COVID-19: Colorectal cancer endoscopic surveillance in IBD
|
Din, Shahida
|
|
|
|
7 |
p. 526
|
artikel
|
| 31 |
Cuts to UK official development assistance budget jeopardise global viral hepatitis elimination goals
|
Lemoine, Maud
|
|
|
|
7 |
p. 527-528
|
artikel
|
| 32 |
Defining difficult-to-treat inflammatory bowel disease: why and how
|
Danese, Silvio
|
|
|
|
7 |
p. 520-522
|
artikel
|
| 33 |
Determining risk factors for mortality in liver transplant patients with COVID-19
|
Webb, Gwilym J
|
|
|
|
7 |
p. 643-644
|
artikel
|
| 34 |
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial
|
Taylor, Stuart A
|
|
2019
|
|
7 |
p. 529-537
|
artikel
|
| 35 |
Digestive Disease Week 2017
|
Brierley, Rob
|
|
2017
|
|
7 |
p. 473-474
|
artikel
|
| 36 |
Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial
|
Yamada, Yasuhide
|
|
2019
|
|
7 |
p. 501-510
|
artikel
|
| 37 |
Drinking alone: COVID-19, lockdown, and alcohol-related harm
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
7 |
p. 625
|
artikel
|
| 38 |
Early detection of pancreatic cancer
|
Pereira, Stephen P
|
|
|
|
7 |
p. 698-710
|
artikel
|
| 39 |
Early-onset colorectal cancer: trends and challenges
|
Cavestro, Giulia Martina
|
|
2019
|
|
7 |
p. 491-492
|
artikel
|
| 40 |
Effect of the COVID-19 pandemic on procedure volumes in gastroenterology in the Netherlands
|
Sonneveld, Milan J
|
|
|
|
7 |
p. 595-598
|
artikel
|
| 41 |
Endophenotyping eosinophilic oesophagitis: a new era for management?
|
Keely, Simon
|
|
2018
|
|
7 |
p. 449-450
|
artikel
|
| 42 |
Endoscopy: the disco years
|
Mohammadi, Dara
|
|
2017
|
|
7 |
p. 478
|
artikel
|
| 43 |
Enteral nutrition during major surgery: how to proceed after SANICS II
|
Plas, Matthijs
|
|
2018
|
|
7 |
p. 454
|
artikel
|
| 44 |
Enteral nutrition during major surgery: how to proceed after SANICS II – Authors' reply
|
Luyer, Misha D P
|
|
2018
|
|
7 |
p. 455
|
artikel
|
| 45 |
Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study
|
Shoda, Tetsuo
|
|
2018
|
|
7 |
p. 477-488
|
artikel
|
| 46 |
Epitope-specific immunotherapy: a vaccine for coeliac disease?
|
Di Sabatino, Antonio
|
|
2017
|
|
7 |
p. 464-465
|
artikel
|
| 47 |
Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies
|
Goel, Gautam
|
|
2017
|
|
7 |
p. 479-493
|
artikel
|
| 48 |
ESPGHAN Annual Meeting 2018
|
Van Epps, Heather
|
|
2018
|
|
7 |
p. 456
|
artikel
|
| 49 |
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study
|
Hajarizadeh, Behzad
|
|
|
|
7 |
p. 533-546
|
artikel
|
| 50 |
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study
|
Grebely, Jason
|
|
2017
|
|
7 |
p. 514-520
|
artikel
|
| 51 |
Food-additive emulsifiers: the worst thing since sliced bread?
|
Cox, Selina R
|
|
|
|
7 |
p. 532
|
artikel
|
| 52 |
Food for thought: The Angry Chef
|
Tang, Paul Kiet
|
|
2018
|
|
7 |
p. 459
|
artikel
|
| 53 |
Food insecurity in the UK: a public health issue left to fester
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
7 |
p. 585
|
artikel
|
| 54 |
Gastrointestinal tract involvement in Klippel–Trénaunay syndrome
|
Sepulveda, Andrea
|
|
2018
|
|
7 |
p. 518
|
artikel
|
| 55 |
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study
|
Fewings, Eleanor
|
|
2018
|
|
7 |
p. 489-498
|
artikel
|
| 56 |
Gleaning insight from the PISA trials
|
Tozer, Philip James
|
|
|
|
7 |
p. 587-588
|
artikel
|
| 57 |
Global alcohol targets unlikely to be met
|
The Lancet Gastroenterology & Hepatology,
|
|
2019
|
|
7 |
p. 489
|
artikel
|
| 58 |
Global epidemiology and prevention of colorectal cancer
|
Song, Mingyang
|
|
|
|
7 |
p. 588-590
|
artikel
|
| 59 |
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
|
|
|
|
|
7 |
p. 627-647
|
artikel
|
| 60 |
Green endoscopy: a call for sustainability in the midst of COVID-19
|
Maurice, James B
|
|
|
|
7 |
p. 636-638
|
artikel
|
| 61 |
Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial
|
Andresen, Viola
|
|
|
|
7 |
p. 658-666
|
artikel
|
| 62 |
Hepatitis C in pregnancy and the TiP-HepC registry
|
Gupta, Neil
|
|
|
|
7 |
p. 598-599
|
artikel
|
| 63 |
Implications of gastrointestinal manifestations of COVID-19
|
Yang, Lijing
|
|
|
|
7 |
p. 629-630
|
artikel
|
| 64 |
Improving duodenoscope safety: a work in progress
|
Gilbert, Judith A
|
|
2019
|
|
7 |
p. 497
|
artikel
|
| 65 |
Ingestion of high-power magnets: cause for concern
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
7 |
p. 511
|
artikel
|
| 66 |
Intestinal microbiota transplantation: do not forget the metabolites
|
Mullish, Benjamin H
|
|
|
|
7 |
p. 594
|
artikel
|
| 67 |
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus
|
Ananthakrishnan, Ashwin N
|
|
|
|
7 |
p. 666-678
|
artikel
|
| 68 |
Long-term safety of laparoscopic rectal cancer resection
|
Tanis, Pieter J
|
|
|
|
7 |
p. 516-518
|
artikel
|
| 69 |
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
|
Mao, Ren
|
|
|
|
7 |
p. 667-678
|
artikel
|
| 70 |
Misoprostol for NSAID-induced small bowel erosions and ulcers
|
Rockall, Timothy A
|
|
2018
|
|
7 |
p. 447-448
|
artikel
|
| 71 |
Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Taha, Ali S
|
|
2018
|
|
7 |
p. 469-476
|
artikel
|
| 72 |
Missed opportunities for intervention in alcohol-related liver disease in the UK
|
Burton, Robyn
|
|
2017
|
|
7 |
p. 469-471
|
artikel
|
| 73 |
Molecular radionuclide imaging of pancreatic neoplasms
|
Panda, Ananya
|
|
2019
|
|
7 |
p. 559-570
|
artikel
|
| 74 |
More is not always better: triplet chemotherapy and advanced gastric cancer
|
Fokter-Dovnik, Nina
|
|
2019
|
|
7 |
p. 490-491
|
artikel
|
| 75 |
Mystery outbreak of severe acute hepatitis in children
|
Samarasekera, Udani
|
|
|
|
7 |
p. 601
|
artikel
|
| 76 |
Nationwide hepatitis C virus screening and treatment of adolescents in Egyptian schools
|
Kamal, Ehab
|
|
|
|
7 |
p. 658-665
|
artikel
|
| 77 |
New insights on the surgical management of ulcerative colitis in the 21st century
|
Kotze, Paulo G
|
|
|
|
7 |
p. 679-688
|
artikel
|
| 78 |
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
|
Targher, Giovanni
|
|
|
|
7 |
p. 578-588
|
artikel
|
| 79 |
Non-alcoholic fatty liver disease and the interface between primary and secondary care
|
Tsochatzis, Emmanuel A
|
|
2018
|
|
7 |
p. 509-517
|
artikel
|
| 80 |
Obesity management: gastroenterologists take centre stage
|
The Lancet Gastroenterology & Hepatology,
|
|
2017
|
|
7 |
p. 463
|
artikel
|
| 81 |
Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial
|
Welzel, Tania M
|
|
2017
|
|
7 |
p. 494-500
|
artikel
|
| 82 |
Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial
|
Park, Ji Won
|
|
|
|
7 |
p. 569-577
|
artikel
|
| 83 |
Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study
|
Sonneveld, Milan J
|
|
2019
|
|
7 |
p. 538-544
|
artikel
|
| 84 |
PALB2 as a familial gastric cancer gene: is the wait over?
|
Carvajal-Carmona, Luis G
|
|
2018
|
|
7 |
p. 451-452
|
artikel
|
| 85 |
Patient input into future clinical research in acute and chronic pancreatitis
|
van Dijk, Sven M
|
|
2018
|
|
7 |
p. 452-453
|
artikel
|
| 86 |
Patterns of care for inflammatory bowel disease in China during the COVID-19 pandemic
|
Chen, Yan
|
|
|
|
7 |
p. 632-634
|
artikel
|
| 87 |
Pierre-Alain Clavien: first a surgeon, and first a scientist
|
Morgan, Jules
|
|
2017
|
|
7 |
p. 477-478
|
artikel
|
| 88 |
Prevention of COVID-19 in patients with IBD
|
Segal, Jonathan P
|
|
|
|
7 |
p. 639-640
|
artikel
|
| 89 |
Prevention of COVID-19 in patients with IBD – Authors' reply
|
Ding, Nik Sheng
|
|
|
|
7 |
p. 640-641
|
artikel
|
| 90 |
Probiotics and COVID-19: one size does not fit all
|
Mak, Joyce W Y
|
|
|
|
7 |
p. 644-645
|
artikel
|
| 91 |
Promoting the term MAFLD: China in action
|
Zhang, Xin-Lei
|
|
|
|
7 |
p. 598
|
artikel
|
| 92 |
Protecting patients with IBD during the COVID-19 pandemic
|
Fiorino, Gionata
|
|
|
|
7 |
p. 639
|
artikel
|
| 93 |
Rapid HCV RNA testing: removing the final obstacle to elimination
|
Cooper, Curtis
|
|
2017
|
|
7 |
p. 468-469
|
artikel
|
| 94 |
René Laennec: no going back
|
Burki, Talha Khan
|
|
2018
|
|
7 |
p. 458
|
artikel
|
| 95 |
Research in Brief
|
Baker, Holly
|
|
|
|
7 |
p. 602
|
artikel
|
| 96 |
Research in brief
|
Baker, Holly
|
|
2018
|
|
7 |
p. 457
|
artikel
|
| 97 |
Research in brief
|
Baker, Holly
|
|
2017
|
|
7 |
p. 475
|
artikel
|
| 98 |
Research in brief
|
Baker, Holly
|
|
2019
|
|
7 |
p. 498
|
artikel
|
| 99 |
Research in Brief
|
Baker, Holly
|
|
|
|
7 |
p. 531
|
artikel
|
| 100 |
Research in brief
|
Baker, Holly
|
|
|
|
7 |
p. 647
|
artikel
|
| 101 |
Resolution of inflammation in inflammatory bowel disease
|
Rogler, Gerhard
|
|
2017
|
|
7 |
p. 521-530
|
artikel
|
| 102 |
Resumption of daily services in a gastroenterology department in Guangzhou, China, in the wake of COVID-19
|
Han, Jing
|
|
|
|
7 |
p. 645-646
|
artikel
|
| 103 |
Safely reprocessing duodenoscopes: current evidence and future directions
|
Rubin, Zachary A
|
|
2018
|
|
7 |
p. 499-508
|
artikel
|
| 104 |
SARS-CoV-2 vaccination for patients with inflammatory bowel disease
|
Garrido, Hannah M Garcia
|
|
|
|
7 |
p. 523
|
artikel
|
| 105 |
SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
|
Alexander, James L
|
|
|
|
7 |
p. 523-524
|
artikel
|
| 106 |
SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
|
Alexander, James L
|
|
|
|
7 |
p. 528-529
|
artikel
|
| 107 |
Scoping the problem: endoscopy-associated infections
|
The Lancet Gastroenterology & Hepatology,
|
|
2018
|
|
7 |
p. 445
|
artikel
|
| 108 |
Screening FMT donors during the COVID-19 pandemic: a protocol for stool SARS-CoV-2 viral quantification
|
Ng, Siew C
|
|
|
|
7 |
p. 642-643
|
artikel
|
| 109 |
Serenity in sobriety
|
Denny, Victoria
|
|
2018
|
|
7 |
p. 458
|
artikel
|
| 110 |
Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens
|
Brodin, Petter
|
|
|
|
7 |
p. 594-595
|
artikel
|
| 111 |
Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study
|
Feld, Jordan J
|
|
|
|
7 |
p. 649-657
|
artikel
|
| 112 |
Shortening treatment with direct-acting antivirals in HCV-positive organ transplantation
|
Holmes, Jacinta A
|
|
|
|
7 |
p. 626-627
|
artikel
|
| 113 |
Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial
|
Meima-van Praag, Elise M
|
|
|
|
7 |
p. 617-626
|
artikel
|
| 114 |
Spontaneous rectus sheath haematoma
|
Carrascosa, Miguel F
|
|
2017
|
|
7 |
p. 538
|
artikel
|
| 115 |
Stent insertion for incurable oesophageal carcinoma: what is the optimal treatment?
|
Tian, Dong
|
|
|
|
7 |
p. 524-525
|
artikel
|
| 116 |
Stent insertion for incurable oesophageal carcinoma: what is the optimal treatment? – Authors' reply
|
Byrne, Anthony
|
|
|
|
7 |
p. 525
|
artikel
|
| 117 |
Supporting travel in patients with inflammatory bowel disease
|
Mushtaq, Ammara
|
|
2019
|
|
7 |
p. 499-500
|
artikel
|
| 118 |
The current and potential future role of capsule technology in Crohn's disease
|
Armstrong, Paul
|
|
2019
|
|
7 |
p. 493-494
|
artikel
|
| 119 |
The end of bursectomy for gastric cancer?
|
Byrne, Ben E
|
|
2018
|
|
7 |
p. 446-447
|
artikel
|
| 120 |
The International Liver Congress 2017
|
Van Epps, Heather
|
|
2017
|
|
7 |
p. 472
|
artikel
|
| 121 |
Therapeutic targeting of VEGFR2 in HBV-associated hepatocellular carcinoma
|
Pinato, David J
|
|
|
|
7 |
p. 515-516
|
artikel
|
| 122 |
The shifting epidemiology of colorectal cancer
|
The Lancet Gastroenterology & Hepatology,
|
|
2019
|
|
7 |
p. 489
|
artikel
|
| 123 |
Thinking outside the box: a more efficient diagnostic approach in metastatic colorectal cancer
|
Schreyer, Andreas G
|
|
2019
|
|
7 |
p. 494-495
|
artikel
|
| 124 |
Towards meaningful change: the future of gastroenterology belongs to women, diversity, equity, and inclusion
|
Matharoo, Manmeet K
|
|
|
|
7 |
p. 518-520
|
artikel
|
| 125 |
Treatment-as-prevention in prison settings: a growing evidence base for HCV elimination efforts
|
Tavoschi, Lara
|
|
|
|
7 |
p. 512-513
|
artikel
|
| 126 |
Treatment of chronic hepatitis C: can complexity pave the way towards elimination?
|
Invernizzi, Federica
|
|
2017
|
|
7 |
p. 465-466
|
artikel
|
| 127 |
Trust your gut instincts
|
Tang, Paul Kiet
|
|
2017
|
|
7 |
p. 476-477
|
artikel
|
| 128 |
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy
|
Black, Mairead
|
|
|
|
7 |
p. 513-515
|
artikel
|
| 129 |
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis
|
Ovadia, Caroline
|
|
|
|
7 |
p. 547-558
|
artikel
|
| 130 |
USPSTF: colorectal cancer screening in the US from 45 years
|
Burki, Talha K
|
|
|
|
7 |
p. 530
|
artikel
|
| 131 |
Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey
|
D'Amico, Ferdinando
|
|
|
|
7 |
p. 631-632
|
artikel
|
| 132 |
Wastewater monitoring of SARS-CoV-2: lessons from illicit drug policy
|
Lancaster, Kari
|
|
|
|
7 |
p. 641-642
|
artikel
|
| 133 |
What is there to learn for watch-and-wait in rectal cancer?
|
van der Valk, Maxime J M
|
|
2017
|
|
7 |
p. 467-468
|
artikel
|
| 134 |
Whitish elevated lesion in the oesophagus: verrucous carcinoma
|
Katano, Takahito
|
|
|
|
7 |
p. 596
|
artikel
|
Tijdschrift beschrijving